Session Details
[2-YIA-DC]YIA-DC
Tue. Mar 17, 2026 8:45 AM - 10:00 AM JST
Tue. Mar 17, 2026 11:45 PM - 1:00 AM UTC
Tue. Mar 17, 2026 11:45 PM - 1:00 AM UTC
Room 9(B101)
Chair:Akihiro Mouri(Fujita Health University Graduate School of Medical Sciences), Yasushi Yabuki(Institute of Molecular Embryology and Genetics, Kumamoto University)
[2-YIA-DC-06]Abnormal distribution of excitatory neurons born at E13 is associated with social deficits in prenatally VPA-exposed mice
*Hiroki Ueno1,2, Ryotaro Kodera2, Yuka Nakai1,2, Keita Deminami1, Zhiwen Zhou2, Hitoshi Hashimoto1,3,4,5,6, Atsushi Kasai2 (1. Lab Mol Neuropharmacol, Graduate School of Pharmaceutical Sciences, Osaka University, 2. Department of Systems Neuropharmacology, RIEM, Nagoya University, 3. Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, 4. Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 5. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, 6. D3 Center, Osaka University)
[2-YIA-DC-07]Mice Learn to Discriminate Hippocampal Stimulation Sites
*Shiyori Tanaka1, Nobuyoshi Matsumoto1,2, Yuji Ikegaya1,2 (1. The University of Tokyo, 2. Inst. for AI and Beyond)
[2-YIA-DC-08]Mechanistic analysis of how ceramide-1-phosphate regulates microglial activation
*Masumi Sano1, Hiroyuki Nakamura1 (1. Grad. Sch. of Pharm. Sci., Chiba Univ.)
[2-YIA-DC-09]Targeting the retinoblastoma protein in Alzheimer’s disease: implications of heterophyllin B for enhancing cognitive resilience
*Jiahui Jiang1, Zhiyou Yang2 (1. University of Toyama, 2. Guangdong Ocean University)
[2-YIA-DC-10]Environmental enrichment rescues neurodevelopmental defects in a mouse model of 3q29 deletion syndrome
*Rei Endo1, Yuya Akimoto1,8, Hotaka Fukushima1, Daiki Miura1, Hitoshi Hashimoto2,3,4,5,6,7, Ryota Hashimoto7, Takanobu Nakazawa1,7 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr., 2. Grad. Sch. Pharmaceut. Sci., Osaka Univ., 3. 3.United Grad. Sch. Child Dev., Osaka Univ, 4. D3 Center, Osaka Univ., 5. Transdimensional Life Imaging Div., Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 6. Grad. Sch. Med., Osaka Univ., 7. Dept. Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 8. WDB CO., LTD. EUREKA Company)
